journal article·2017-10-09

In Vitro and In Vivo Characterization of Premixed PMMA-CaP Composite Bone Cements

Shant Aghyarian, Elizabeth Bentley, Thao N. Hoang, Izabelle M. Gindri, Victor Kosmopoulos, Harry K. W. Kim, Danieli C. Rodrigues

Publisher page

Abstract

Acrylic bone cements, although successful in the field of orthopedics, suffer from a lack of bioactivity, not truly integrating with surrounding bone. Bioactive fixation is expected to enhance cement performance because of the natural interlocking and bonding with bone, which can improve the augmentative potential of the material in applications such as vertebroplasty (VP). In a recent study, two composite cements (PMMA-hydroxyapatite and PMMA-brushite) showed promising results demonstrating no deterioration in rheological and mechanical properties after CaP filler addition. In this study, the dynamic properties of the cements were investigated in vitro and in vivo. The hypothesis was that these composite cements will provide osseointegration around the implanted cement and increase new bone formation, thus decreasing the risk of bone structural failure. The effects of CaP elution were thus analyzed in vitro using these cements. Mass-loss, pore formation, and mechanical changes were tracked after cement immersion in Hank's salt solution. PMMA-brushite was the only cement with a significant mass loss; however it showed low bulk porosity. Surface porosity increases were observed in both composite cements. Mechanical properties were maintained after cement immersion. In vitro culture studies tested preosteoblast cell viability and differentiation on the cement surface. Cell viability was demonstrated with MTT assay and confirmed on the cement surface. ALP assays showed no inhibition of osteoblast differentiation on the cement surface. In vivo experiments were performed using a rat tibiae model to demonstrate bone ingrowth around the implanted cements. Critical size defects were created and then filled with the cements. The animal studies showed no loss in mechanical strength after implantation and increased bone ingrowth around the composite cements. In summary, the composite cements provided bioactivity without sacrificing mechanical strength.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Spinal Fractures and Fixation Techniques · Spine and Intervertebral Disc Pathology · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomaterials for Osseointegration and Novel Engineering Laboratory (BONE Lab), Department of Bioengineering, University of Texas at Dallas, Richardson, Texas 75080, United States

Department of Orthopaedic Surgery, University of North Texas Health Science Center (UNTHSC), Fort Worth, Texas 76107, United States

Department of Materials Science and Engineering, University of North Texas, Denton, Texas 76203, United States

Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, 2222 Welborn Street, Dallas, Texas 75219, United States

Department of Orthopaedic Surgery, UT Southwestern Medical Center, Dallas, Texas 75390, United States

Funding

University of Texas System

References (43)

Show source-provided references
1. 10.1007/s00586-012-2314-z10.1007/s00586-012-2314-z ↗
2. 10.1186/1749-799X-6-4310.1186/1749-799X-6-43 ↗
3. Wark, B. J. D.Studies of drugs and other measures to prevent and treat osteoporosis; a guide for non-experts. 2005, http://who.int/ageing/publications/noncommunicable/en/.
4. 10.1002/jbm.b.3039810.1002/jbm.b.30398 ↗
5. Provenzano M. J. · Am. J. Neuroradiol. · 2004 · 25 · 1286
6. 10.1016/j.spinee.2005.02.02010.1016/j.spinee.2005.02.020 ↗
7. Ratner B. D. · 2004
8. 10.1016/j.msec.2013.04.04210.1016/j.msec.2013.04.042 ↗
9. 10.1007/s12306-011-0130-y10.1007/s12306-011-0130-y ↗
10. 10.1016/j.biomaterials.2005.03.04910.1016/j.biomaterials.2005.03.049 ↗
11. 10.1016/j.actbio.2013.11.00110.1016/j.actbio.2013.11.001 ↗
12. 10.1007/s00132-013-2062-810.1007/s00132-013-2062-8 ↗
13. 10.1080/0268869070182435410.1080/02688690701824354 ↗
14. 10.12659/AJCR.89771910.12659/AJCR.897719 ↗
15. 10.7759/cureus.105810.7759/cureus.1058 ↗
16. 10.1007/s00586-011-1945-910.1007/s00586-011-1945-9 ↗
17. 10.1177/088532821454477010.1177/0885328214544770 ↗
18. 10.1016/j.jmbbm.2015.06.02210.1016/j.jmbbm.2015.06.022 ↗
19. 10.1002/jor.2349110.1002/jor.23491 ↗
20. 10.1016/j.reuma.2012.07.00510.1016/j.reuma.2012.07.005 ↗
21. 10.2214/ajr.183.4.183109710.2214/ajr.183.4.1831097 ↗
22. 10.1097/BRS.0b013e318281507a10.1097/BRS.0b013e318281507a ↗
23. 10.1007/s00402-011-1271-z10.1007/s00402-011-1271-z ↗
24. Barrère F. · Int. J. Nanomed. · 2006 · 1 · 317
25. 10.1615/JLongTermEffMedImplants.v13.i1.5010.1615/JLongTermEffMedImplants.v13.i1.50 ↗
26. 10.1002/jbm.b.3139610.1002/jbm.b.31396 ↗
27. ASTM F451-016: Standard Specification for Acrylic Bone Cement;ASTM International:West Conshohocken, PA, 2010.
28. ASTM D790-17: Standard Test Methods for Flexural Properties of Unreinforced and Reinforced Plastics and Electrical Insulating Materials 1;ASTM International:West Conshohocken, PA, 2011.
29. ASTM D5045-14: Standard Test Methods for Plane-Strain Fracture Toughness and Strain Energy Release Rate of Plastic Materials;ASTM International:West Conshohocken, PA, 1996.
30. ASTM F2118-10: Standard Test Method for Constant Amplitude of Force Controlled Fatigue Testing of Acrylic Bone Cement Materials;ASTM International:West Conshohocken, PA, 2010.
31. ISO 10993-5:2009. Biological Evaluation of Medical Devices–Part 5: Tests for in VItro Cytotoxicity;International Organization for Standardization:Geneva, Switzerland, 2009.
32. Mayr-Wohlfart U. · Acta Chir. Orthop. Traumatol. Cech. · 2008 · 75 · 44310.55095/achot2008/082 ↗
33. 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-110.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
34. 10.1155/2015/57507910.1155/2015/575079 ↗
35. 10.1002/jbm.b.3161910.1002/jbm.b.31619 ↗
36. 10.1016/j.spinee.2007.06.01210.1016/j.spinee.2007.06.012 ↗
37. 10.1016/j.spinee.2003.07.00310.1016/j.spinee.2003.07.003 ↗
38. 10.1053/joca.1998.023010.1053/joca.1998.0230 ↗
39. 10.1016/S0140-6736(10)62349-510.1016/S0140-6736(10)62349-5 ↗
40. 10.1359/jbmr.1999.14.6.89310.1359/jbmr.1999.14.6.893 ↗
41. 10.1016/j.biomaterials.2013.07.03610.1016/j.biomaterials.2013.07.036 ↗
42. 10.1111/j.1600-0501.2011.02166.x10.1111/j.1600-0501.2011.02166.x ↗
43. 10.1016/8756-3282(92)90073-610.1016/8756-3282(92)90073-6 ↗